PharmaShots | Incisive News in 3 Shots

Subscribe Now

During

Takeda Reports Results of Entyvio (vedolizumab) in Interim Analysis from VISIBLE OLE Study for Moderately to Severely Active Ulcerative Colitis

Takeda Reports Results of Entyvio (vedolizumab) in Interim Analysis from VISIBLE OLE Study for Moderately to Severely Active Ulcer...

October 13, 2020

Genentech' Gavreto (pralsetinib) Receives the US FDA's Approval Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer

Genentech' Gavreto (pralsetinib) Receives the US FDA's Approval Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer

September 7, 2020

VIVUS Expedites the Launch of Telemedicine and Remote Monitoring Modules for Effective Patient Care During COVID-19

VIVUS Expedites the Launch of Telemedicine and Remote Monitoring Modules for Effective Patient Care During COVID-19

April 1, 2020

FDA Divulges Guidance for Conducting Clinical Studies During COVID-19 Pandemic

FDA Divulges Guidance for Conducting Clinical Studies During COVID-19 Pandemic

March 19, 2020

Novartis' LysaKare (arginine hydrochloride/lysine hydrochloride) Solution Receives CHMP's Positive Opinion for Reduction of Kidney Exposure to Radiation During PPRT with Lutathera

Novartis' LysaKare (arginine hydrochloride/lysine hydrochloride) Solution Receives CHMP's Positive Opinion for Reduction of Kidney...

June 7, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us